Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: outcome and results of KRAS mutational analysis in plasma
- Karen-Lise Garm Spindler
- , Morten Sørensen
- , Niels Pallisgaard
- , Rikke Andersen
- , Birgitte Mayland Havelund
- , John Ploen
- , Ulrik Lassen
- , Leif Anders Jakobsen
62
Citationer
(Scopus)